Investor Information

Algeta is now part of Bayer.

Latest releases

Thomas Ramdahl appointed Managing Director of Algeta ASA

Algeta ASA: Bayer's voluntary cash offer to acquire the entire issued share capital of Algeta is successful

Investor relations

Algeta is now part of Bayer. Please see Investor Relations for more information


OSE announcements

Price information from Oslo Stock Exchange

Primary Insiders Notices

Disclosure of Shareholdings Notices

All Stock Exchange Notices


Algeta's financing

Information on Algeta's financing in 2012. Read more

Information on Algeta's financing in 2013. Read more

Bayer offer for Algeta

Offer document available. Read more


Corporate strategy

Algeta’s strategy is to build a commercial operation as well as expand its portfolio of oncology product candidates.

Find out more


Algeta is managed by experienced pharmaceutical professionals.

Find out more

Contact us

If you'd like to know more about Algeta and our research, please do get in touch – we'd love to hear from you.

Get in touch